Friday 6 November 2026 Export IDXX’s income statement to Excel — free account

IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.3 billion, up 10.4% from fiscal 2024.

Revenue: +9.86%
EPS: +17.3%
Free cash flow: +17.6%
Total debt: −28.6%

Quarter to September 2026, against a year earlier

675.64 4.93 +0.74%

Follow IDXX

Alert me

Market cap: $52.8B
P/E: 45.3×
Fwd P/E: 37.3×
Dividend yield: —
F-score: 8/9
Altman Z: 24.09
Beneish M: −2.50
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

IDEXX Laboratories, Inc. (IDXX) Price to free cash flow

Alert me on Price to free cash flow

As of 6 November 2026, IDEXX Laboratories, Inc. (IDXX) trades at a price to free cash flow of 41.0×. Over the past ten years it has ranged from 30.7× (October 2026) to 112× (February 2023); the current reading is higher than 7% of that period. That is above the Diagnostics & Research industry median of 33.7× and above the Healthcare sector median of 20.5×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/IDXX/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="IDEXX Laboratories, Inc. price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/IDXX/metrics/price-to-free-cash-flow">IDEXX Laboratories, Inc. (IDXX) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2025	56.9×	20.30%
FY2024	47.3×	(20.71%)
FY2023	59.6×	(32.53%)
FY2022	88.4×	(0.50%)
FY2021	88.8×	12.53%
FY2020	78.9×	4.17%
FY2019	75.8×	28.89%
FY2018	58.8×	25.89%
FY2017	46.7×	21.34%
FY2016	38.5×	(20.93%)

Period	Price to free cash flow	Change
Sep 2026	31.7×	(5.76%)
Jun 2026	33.6×	(20.56%)
Mar 2026	42.3×	(25.64%)
Dec 2025	56.9×	(4.05%)
43 more quarters	Free account

Against its own ten years

Low 30.7× High 112×

Ten-year median 61.9×

Current reading's percentile 7

Company	Price to free cash flow
DGX Quest Diagnostics Incorporated compare	20.5×
IQV IQVIA Holdings Inc. compare	21.5×
LH Labcorp Holdings Inc. compare	25.7×
ILMN Illumina, Inc. compare	30.9×
A Agilent Technologies, Inc. compare	38.8×
MTD Mettler-Toledo International, Inc. compare	39.4×
IDXX IDEXX Laboratories, Inc.	41.0×
WAT Waters Corporation compare	174×
NTRA Natera, Inc. compare	873×
Diagnostics & Research industry median	33.7×
Healthcare sector median	20.5×
Market median	14.0×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

IDEXX Laboratories, Inc. (IDXX) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on IDXX

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on IDXX

Stockrow Weekly